[1] 隰建成, 周宝桐. 脓毒症过程中的炎症介质与细胞凋亡关系的研究进展[J]. 中国危重病急救医学, 2000, 12(6):378-380.
[2] Wang J, Liu Y T, Xiao L, et al. Anti-inflammatory effects of apigenin in lipopolysaccharide-induced inflammatory in acute lung injury by suppressing COX-2 and NF-κB pathway[J]. Inflammation, 2014, 37(6):2085-2090.
[3] Idell S. Coagulation, fibrinolysis, and fibrin deposition in acute lung injury[J].Crit Care Med, 2003, 31(4 Suppl):S213-S220.
[4] Gunther A, Mosavi P, Heinemann S, et al. Alveolar fibrin formation caused by enhanced pneumonia. Comparison and depressed fibrinolytic capacities in severe with the acute respiratory distress syndrome[J]. Am J Respir Crit Care Med, 2000, 161(2 Pt 1):454-462.
[5] Zhong W, Cui Y, Yu Q, et al. Modulation of LPS-stimulated pulmonary inflammation by borneol in murine acute lung injury model[J]. Inflammation, 2014, 37(4):1148-1157.
[6] Bhandary Y P, Shetty S K, Marudamuthu A S, et al. Role of p53-fibrinolytic system cross-talk in the regulation of quartz-induced lung injury[J]. Toxicology and Applied Pharmacology, 2015, 283(2):92-98.
[7] 牛星. 牛肺炎的防治[J]. 中国畜牧兽医文摘, 2016,3:171.
[8] 方青, 高荣, 高英杰, 等. 急性肺损伤动物模型的研究现状[J]. 中国畜牧兽医, 2010,37(5):50-54.
[9] Fei A M,Calalang-Colucci M C. Acute lung injury/acute respiratory distress syndrome in sepsis and septic shock[J].Crit Care, 2000,16(2):289-317.
[10] Downey G P,Dong Q,Kruger J, et al. Regulation of neutrophil activation in acute lung injury[J].Chest,1999,116(1 Suppl):46S-54S.
[11] Standiford T J, Ward P A. Therapeutic targeting of acute lung injury and acute respiratory distress syndrome[J]. Translational Research, 2016, 167(1):183-191.
[12] Bao S, Zou Y, Wang B, et al. Ginsenoside Rg1 improves lipopolysaccharide-induced acute lung injury by inhibiting inflammatory responses and modulating infiltration of M2 macrophages[J]. International Immunopharmacology, 2015, 28(1):429-434.
[13] Walters D M, Cho H Y, Kleeberger S R. Oxidative stress and antioxidants in the pathogenesis of pulmonary fibrosis:A potential role for nrf2[J]. Antioxidants and Redox Signalling, 2008, 10(2):321-332.
[14] 梁华平,姚咏明,王正国.创伤后脓毒症的治疗现状小容乐观——预警研究值得重视[J].第三军医大学学报,2011, 33(21):2223-2226.
[15] 孟庆雪, 刘玉芬, 刘静, 等. 肺表面活性蛋白研究进展[J]. 中国畜牧兽医, 2014, 41(3):178-181.
[16] Wynn T A. Integrating mechanisms of pulmonary fibrosis[J]. Journal of Experimental Medicine, 2011, 208(7):1339-1350.
[17] 邱海波, 陈德昌. 急性肺损伤的炎症反应机制与药物治疗探讨[J]. 中国危重病急救医学, 1999, 11(11):678-680.
[18] Bone R C, Grodzin C J, Balk R A. Sepsis:A new hypothesis for pathogenesis of the disease process[J]. Chest, 1997, 112(1):235-243.
[19] 仇佳明. 积雪草粗提取物对脂多糖诱导小鼠急性肺损伤的治疗作用[D]. 长春:吉林大学, 2015.
[20] Taga K, Tosato G. IL-10 inhibits human T cell proliferation and IL-2 production[J]. The Journal of Immunology, 1992, 148(4):1143-1148.
[21] de Waal Malefyt R, Figdor C G, Huijbens R, et al. Effects of IL-13 on phenotype, cytokine production, and cytotoxic function of human monocytes. Comparison with IL-4 and modulation by IFN-gamma or IL-10[J]. The Journal of Immunology, 1993, 151(11):6370-6381.
[22] Keane M P, Donnelly S C, Belperio J A, et al. Imbalance in the expression of CXC chemokines correlates with bronchoalveolar lavage fluid angiogenic activity and procollagen levels in acute respiratory distress syndrome[J]. The Journal of Immunology, 2002, 169(11):6515-6521.
[23] Wolthuis E K, Vlaar A P J, Choi G, et al. Recombinant human soluble tumor necrosis factor-alpha receptor fusion protein partly attenuates ventilator-induced lung injury[J]. Shock, 2009, 31(3):262-266.
[24] Cross L J M, Matthay M A. Biomarkers in acute lung injury:Insights into the pathogenesis of acute lung injury[J]. Critical Care Clinics, 2011, 27(2):355-377.
[25] Matute-Bello G, Winn R K, Jonas M, et al. Fas(CD95)induces alveolar epithelial cell apoptosis in vivo:Implications for acute pulmonary inflammation[J].Am J Pathol,2001,158:153-161.
[26] 夏道奎,刘云,胡旭.体外循环手术后血浆PAF PAF、IL-8、IFN-γ的变化及其意义[J]. 中国胸心血管外科临床杂志,2014,21(2):212-215. |